Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression

Toxicology and Applied Pharmacology

Volumn 229, Issue 2, 2008, Pages 227-231

  Rossiello, Maria R ^a,b   Rotunno, Crescenzia ^a,b   Coluccia, Addolorata ^a,b   Carratù, Maria R ^a,b   Di Santo, Angelomaria ^a,b   Evangelista, Virgilio ^a,b   Semeraro, Nicola ^a,b   Colucci, Mario ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

Author keywords

Cell mediated immune response; Coagulation; Fibrin; Fibrinolysis

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; OCHRATOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SYNTHESIS;

BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MONOCYTES; MYCOTOXINS; OCHRATOXINS; PLASMINOGEN ACTIVATOR INHIBITOR 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOPLASTIN;

EID: 43649096588     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.01.004     Document Type: Article

References (37)

1. Al-Anati L., and Petzinger E. Immunotoxic activity of ochratoxin A. J. Vet. Pharmacol. Ther. 29 (2006) 79-90
2. Alvarez-Erviti L., Leache C., González-Peñas E., and de Cerain A.L. Alterations induced in vitro by ochratoxin A in rat lymphoid cells. Hum. Exp. Toxicol. 24 (2005) 459-466
3. Bugge T.H., Kombrinck K.W., Flick M.J., Daugherty C.C., Danton M.J., and Degen J.L. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87 (1996) 709-719
4. Camerer E., Kolstø A.B., and Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb. Res. 81 (1996) 1-41
5. Degen J.L., Bugge T.H., and Goguen J.D. Fibrin and fibrinolysis in infection and host defense. J. Thromb. Haemost. 5 suppl. 1 (2007) 24-31
6. Dirheimer G., and Creppy E.E. Mechanism of action of ochratoxin A. IARC Sci. Publ. 115 (1991) 171-186
7. Drake T.A., Morrissey J.H., and Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am. J. Pathol. 134 (1989) 1087-1097
8. Flick M.J., Du X., Witte D.P., Jirousková M., Soloviev D.A., Busuttil S.J., Plow E.F., and Degen J.L. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J. Clin. Invest. 113 (2004) 1596-1606
9. Heller M., Rosner H., Burkert B., Möller U., Hinsching A., Rohrmann B., Thierbach S., and Köhler H. In vitro studies into the influence of ochratoxin A on the production of tumor necrosis factor alpha by the human monocytic cell line THP-1. Dtsch. Tierarztl. Wochenschr. 109 (2002) 200-205
10. Imamura T., Iyama K., Takeya M., Kambara T., and Nakamura S. Role of macrophage tissue factor in the development of the delayed hypersensitivity reaction in monkey skin. Cell. Immunol. 152 (1993) 614-622
11. Ishikawa N., Endo Y., and Sasaki T. Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer. Jpn. J. Cancer Res. 87 (1996) 480-487
12. Johnson L.L., Berggren K.N., Szaba F.M., Chen W., and Smiley S.T. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197 (2003) 801-806
13. Jørgensen K. Occurrence of ochratoxin A in commodities and processed food-a review of EU occurrence data. Food Addit. Contam. 22 Suppl 1 (2005) 26-30
14. Kruithof E.K., Baker M.S., and Bunn C.L. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86 (1995) 4007-4024
15. Levi M., and van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc. Med. 15 (2005) 254-259
16. Lyberg T., and Prydz H. The role of cellular cooperation in thromboplastin synthesis. Nouv. Rev. Fr. Hematol. 25 (1983) 291-293
17. Marin M.L., Murtha J., Dong W., and Pestka J.J. Effects of mycotoxins on cytokine production and proliferation in EL-4 thymoma cells. J. Toxicol. Environ. Health 48 (1996) 379-396
18. Medcalf R.L., and Stasinopoulos S.J. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J. 272 (2005) 4858-4867
19. Monroe D.M., and Key N.S. The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J. Thromb. Haemost. 5 (2007) 1097-1105
20. Müller G., Rosner H., Rohrmann B., Erler W., Geschwend G., Gräfe U., Burkert B., Möller U., Diller R., Sachse K., and Köhler H. Effects of the mycotoxin ochratoxin A and some of its metabolites on the human cell line THP-1. Toxicology 184 (2003) 69-82
21. Müller G., Burkert B., Möller U., Diller R., Rohrmann B., Rosner H., and Köhler H. Ochratoxin A and some of its derivatives modulate radical formation of porcine blood monocytes and granulocytes. Toxicology 199 (2004) 251-259
22. Nakajima-Iijima S., Hamada H., Reddy P., and Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 6133-6137
23. Napoleone E., Di Santo A., and Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood, 89 (1997) 541-549
24. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul. Fibrinolysis 9 Suppl 1 (1998) S9-S14
25. Pfohl-Leszkowicz A., and Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 51 (2007) 61-99
26. Rao L.V., and Pendurthi U.R. Tissue factor-factor VIIa signaling. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 47-56
27. Ringot D., Chango A., Schneider Y.J., and Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 159 (2006) 18-46
28. Rossiello M.R., Italia A., Stramaglia A.M., Gesualdo L., Grandaliano G., Schena F.P., Semeraro N., and Colucci M. Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cells. Thromb. Haemost. 87 (2000) 453-459
29. Ryan J., and Geczy C. Coagulation and the expression of cell-mediated immunity. Immunol. Cell. Biol. 65 (1987) 127-139
30. Scarpati E.M., Wen D., Broze G.J., Miletich J.P., Flandermeyer R.R., Siegel N.R., and Sadler J.E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 26 (1987) 5234-5238
31. Schwager I., and Jungi T.W. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 83 (1994) 152-160
32. Scott P.M. Biomarkers of human exposure to ochratoxin A. Food Addit. Contam. 22 Suppl. 1 (2005) 99-107
33. Semeraro N., and Colucci M. Tissue factor in health and disease. Thromb. Haemost. 78 (1997) 759-764
34. Semeraro N., and Colucci M. Inflammation and thrombosis. In: Arnout J., de Gaetano G., Hoylaerts M., Peerlinck K., Van Geet C., and Verhaeghe R. (Eds). Thrombosis. Fundamental and Clinical Aspects (2003), Leuven University Press, Leuven 433-459
35. Semeraro N., Biondi A., Lorenzet R., Locati D., Mantovani A., and Donati M.B. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology 50 (1983) 529-535
36. van der Logt C.P., Dirven R.J., Reitsma P.H., and Bertina R.M. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester. Blood Coagul. Fibrinolysis 5 (1994) 211-220
37. Ye R.D., Wun T.C., and Sadle J.E. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J. Biol. Chem. 262 (1987) 3718-3725